Related Experiment Video
Updated: Mar 16, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Health Care Maintenance for the Pediatric Patient With Inflammatory Bowel Disease
Ersilia M DeFilippis1, Robbyn Sockolow1, Elaine Barfield2
1Weill Cornell Medical College, New York, New York.
Insights
Pediatric inflammatory bowel disease (IBD) is rising, affecting nearly a quarter of patients under 20. Comprehensive, multidisciplinary care is crucial for monitoring growth, bone health, and potential complications in children with IBD.
Area of Science:
- Pediatric Gastroenterology
- Inflammatory Bowel Disease (IBD) Research
- Child Health Management
Background:
- Inflammatory bowel disease (IBD) diagnosis in patients under 20 years old affects nearly one-quarter of all IBD cases.
- The incidence of pediatric IBD is increasing globally.
- Current management of pediatric IBD shows variability in screening and preventive care protocols.
Purpose of the Study:
- To provide an updated overview of comprehensive care strategies for pediatric patients diagnosed with IBD.
- To highlight the need for a multidisciplinary approach in managing pediatric IBD.
- To emphasize routine monitoring of key health indicators in children with IBD.
Main Methods:
- Review of current literature and clinical guidelines for pediatric IBD management.
- Emphasis on a multidisciplinary team approach involving general practitioners and pediatric gastroenterologists.
- Focus on systematic monitoring of growth, bone health, nutritional status, and vaccination records.
Main Results:
- A significant proportion of IBD patients are diagnosed in childhood, necessitating specialized care.
- Variations in management underscore the need for standardized, comprehensive care protocols.
- Multidisciplinary care facilitates monitoring of growth, bone density, nutrient deficiencies, and vaccination status.
Conclusions:
- Comprehensive, multidisciplinary care is essential for optimizing outcomes in pediatric IBD patients.
- Routine monitoring for disease activity, growth, bone health, and extraintestinal manifestations is critical.
- Early and consistent intervention can mitigate long-term complications associated with pediatric IBD.
Abstract:
Nearly one-quarter of patients with inflammatory bowel disease (IBD) are younger than 20 years of age at diagnosis. Furthermore, the incidence of IBD in children continues to increase. Nevertheless, variation in management exists within the care of patients with IBD with regards to disease screening and preventive care. A multidisciplinary approach that involves the general practitioner and pediatric gastroenterologist is needed to routinely monitor growth, bone health, vitamin and mineral deficiencies, vaccination status, and endoscopic surveillance. It is also important to monitor for extraintestinal manifestations of IBD that may affect the liver, joints, skin, and eyes. The purpose of this article is to provide an updated overview of comprehensive care for pediatric patients with IBD.
More Related Videos
07:38Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
Published on: September 13, 2016
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...